Browsing Recerca by Subject "615"
Now showing items 21-40 of 56
-
Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: a randomized controlled trial
(Neurourology and urodynamics, 2022, 41:962‐972, 2022-04)Aim To evaluate the efficacy of adjuvant, capacitive resistive monopolar radiofrequency (CRMRF, INDIBA) treatment at 448 kHz together with physiotherapeutic techniques compared to a sham treatment with ... -
Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a randomized controlled trial
(Trials, 2021, 22, 356, 2021-05)Background Chronic pelvic pain syndrome (CPPS) is a multifactorial disorder that affects 5.7% to 26.6% of women and 2.2% to 9.7% of men, characterized by hypersensitivity of the central and peripheral ... -
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: preclinical and real-life clinical data
(The Breast, 2022, 62: 1-9, 2022-01)After the expiration of trastuzumab data exclusivity, biosimilar drugs were approved by regulatory agencies; among them, CT-P6 which was approved for the treatment of HER2-positive early- and advanced-breast ... -
Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial study protocol
(BMC Urology, 2021, vol. 21, núm. article 12, 2021-01-28)Background Radical prostatectomy is the gold standard treatment for men with localized prostate cancer. This technique is associated with post-operative urinary incontinence. Pelvic floor physiotherapy ... -
Evaluation of medicine abuse trends in community pharmacies: the medicine abuse observatory (MAO) in a region of Southern Europe
(International Journal of Environmental Research and Public Health, 2021, 18(15), 7818, 2021-07)The misuse of medicines is a global public health concern that needs to be taken into consideration and requires actions across all government sectors and society. The aim of this study is to identify ... -
Evolució de la formació dels estudis en farmàcia
(Circular farmacèutica, 2023, vol. 81, núm. 3, p. 51-52, 2023-09)Avaluar l'evolució de la formació dels estudis en farmàcia. -
Experiences of Spanish nurses in the rollout of nurse prescribing: a qualitative study
(Frontiers in Public Health, 2023, 11:1163492, 2023-05)Introduction: Nurse prescribing has legal recognition in Spain, after a long regulatory process, with confusing, changing legislation that does not fully coincide with the reality of nurses' practice. ... -
Extracellular vesicles and their current role in cancer immunotherapy
(Cancers, 2021-05-10)Extracellular vesicles (EVs) are natural particles formed by the lipid bilayer and released from almost all cell types to the extracellular environment both under physiological conditions and in presence ... -
Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation
(Journal of Molecular Liquids, 2023, vol. 390, part A, 122986, 2023-09)Doxorubicin (DOX) is amongst the most widely used chemotherapeutic drugs against various cancers. However, its controlled biodistribution to the tumor site at the required pharmacokinetics profile ... -
Fisioterapia respiratoria post-COVID-19: algoritmo de decisión terapéutica
(Open Respiratory Archives, 2022, vol. 4, núm. 1, 100139, 2021-10-12)La pandemia causada por la enfermedad de la COVID-19 ha supuesto un gran reto para los profesionales del sistema sociosanitario, intensificándose con el manejo y atención de las manifestaciones clínicas ... -
Glyphosate targets fish monoaminergic systems leading to oxidative stress and anxiety
(Environment International, 2020-11-18)Glyphosate is the active ingredient of some of the most highly produced and used herbicides worldwide. The intensive applications of glyphosate-based herbicides and its half-life in water lead to its ... -
Industria farmacéutica 4.0
(Pharmatech. N.42 (marzo-abril 2019), p.79-82, 2019-03)La implantación de las tecnologías de la industria 4.0 va a producir grandes cambios en la industria química y farmacéutica. Disponer de un modelo claro de lo qué es la industria 4.0 es clave para ... -
Introducción a la química combinatoria
(Afinidad. Vol.59, n.500 (2002), p.314-324, 2002)Durante los últimos diez años la Química Combinatoria se ha convertido en una técnica usual para el descubrimiento y desarrollo de nuevos productos con actividad biológica. El presente minireview pretende ... -
Neuroreflexotherapy for non-specific low-back pain (Review)
(Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003009, 2004-04)Background Among the wide range oftherapeutic alternatives proposed forthe management of low-back pain (LBP), a less widely used technique from Spain, called neuroreflexotherapy (NRT) has claimed to ... -
Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
(eLIFE. Vol.6 (2017), e23545, 2017-04)Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive ... -
Optimització de la resistència a antiinfecciosos en la pràctica clínica
(Circular farmacèutica, 2021, vol. 79, núm. 1, p. 21-23, 2021)Avaluar la idoneïtat de la prescripció d’antibacterians en la gestió clínica de les infeccions bacterianes en un establiment sanitari privat amb una alta rotació de facultatius, per tal de contribuir ... -
Pharmacist intervention program at different rent levels of geriatric healthcare
(Pharmacy, 2017, vol. 5, núm. 2, 2017-05)As a pharmacy service giving pharmaceutical care at different levels of health care for elderly people, we needed a standardization procedure for recording and evaluating pharmacists’ interventions. Our ... -
Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders
(Journal of Translational Genetics and Genomics, 2021, 5:278-287, 2021-07)Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ... -
Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers
(Pharmaceutics, 2022, 14 (5), 999, 2022-05)BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ... -
Pharmacogenetics of antipsychotics: clinical utility and implementation
(Behavioural Brain Research, 2021, vol. 401, 113058, 2020-12)Decades of research have produced extensive evidence of the contribution of genetic factors to the efficacy and toxicity of antipsychotics. Numerous genetic variants in genes controlling drug availability ...